Last updated: 2026-09-24 02:14:40. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Johnson & Johnson (JNJ) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NYSE. The stock is currently priced at $269,17, with a market capitalisation of $649,40B and a P/E ratio of 30,84. Over the past 52 weeks, its price has ranged from $174,83 to $281,07. This page covers its latest market performance, valuation, price trends and company information.
$649,40B | |
$269,47 | |
$281,07 | |
$46,25 | |
$269,19 | |
5,10M | |
7,32M | |
30,84 | |
$281,07 | |
$174,83 | |
1,95% | |
-- |
Johnson & Johnson (JNJ) last closed at $269,19 as of 2026-09-24 00:00:00, unchanged from the previous close of $269,19.
During the latest regular trading session, JNJ traded between $46,25 and $281,07, with a volume of 5,10M shares. The closing price was near the upper end and near the upper end of its 52-week range.
Over the past seven days, Johnson & Johnson (JNJ) moved from $266,32 to $269,17, representing a gain of 1,07% ($2,85).
The stock traded between $260,68 and $273,73 during the period. The latest price is near the middle of the 7-day range, indicating moderate upward.
The average daily volume was 6,87 million shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 88,8%
JNJ is currently trading at $269,17, placing it 88,8% of the way from its 52-week low of $174,83 to its 52-week high of $281,07. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 140800 |
| Exchange | NYSE |
| Company Website |
Eligible investors can buy real shares of Johnson & Johnson (JNJ) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.